Table 4 Logistic analysis of rs2227983 and rs1050171 in EGFR with the risk of Glioma.
SNPID | Genotype | Case, n(%) | PCs, n(%) | Referent | Additive | Dominant | Recessive | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | ||||
AA | 90 (28.0%) | 176 (37.1%) | 1 | ||||||||
rs2227983 (R521K) | AG | 153 (47.7%) | 224 (47.2%) | 1.33 (0.95–1.85) | 0.09 | 1.42 (1.16–1.74) | 0.0007 | 1.52 (1.11–2.07) | 0.008 | 1.72 (1.20–2.46) | 0.003 |
GG | 78 (24.3%) | 75 (15.8%) | 2.07 (1.36–3.14) | 0.0006 | |||||||
GG | 217 (67.4%) | 377 (78.5%) | 1 | ||||||||
rs1050171 (Q787Q) | AG | 95 (29.5%) | 96 (20.0%) | 1.71 (1.22–2.39) | 0.002 | 1.68 (1.26–2.24) | 0.0004 | 1.77 (1.28–2.45) | 0.0006 | 2.26 (0.84–6.08) | 0.10 |
AA | 10 (3.1%) | 7 (1.5%) | 2.60 (0.96–7.01) | 0.06 | |||||||